Notes
Isolation of DPPH Radical Scavengers from the Culture Broth
Journal of Natural Products, 2009, Vol. 72, No. 11 2071
were detected in the chromatogram of the natural product (3). The ratio
of the S/R enantiomers in the natural product mixture was calculated
from the area of their peaks.
of USF-HO25. The culture broth (10 L) was filtered, and the filtrate
was adjusted to pH 3 and extracted with EtOAc (5 L × 3). The
combined EtOAc layer was dried over anhydrous Na2SO4 and filtered,
and the solvent was removed under reduced pressure. The EtOAc extract
(1.8 g) was applied to a silica gel column and eluted with n-hexane/
EtOAc at 3:1, 1:1, and 1:3, then with EtOAc and MeOH. Two fractions
that eluted with n-hexane/EtOAc (1:1) (fraction II, 568.0 mg) and
MeOH (fraction V, 399.0 mg) showed DPPH radical scavenging activity
in the TLC assay.22 Fractions II and V were further purified three times
by Sephadex LH20 column chromatography using MeOH as an eluent.
Subfractions 17 and 18 of fraction II obtained from the third Sephadex
LH20 column were combined and further purified by preparative RP-
HPLC (column: Capcell-Pak C18 SG120, 15 × 250 mm, Shiseido;
mobile phase: 31% CH3CN/H2O), to yield compounds 1 (51.6 mg), 2
(44.3 mg), 3 (0.6 mg), and 4 (4.9 mg). Subfractions 6-11 of fraction
V were combined and evaporated to dryness in Vacuo, and the resulting
residue was purified by preparative RP-HPLC (column: Capcell-Pak
C18 SG120, 15 × 250 mm, Shiseido; mobile phase: 8% CH3CN/H2O)
to yield 5 (60.7 mg).
2-(1H-Indol-3-yl)ethyl 2-hydroxypropanoate (3): colorless oil; UV
(MeOH) λmax (log ꢀ) 222 (4.48), 282 (3.73) nm; 1H NMR, see Table 1;
13C NMR, see Table 1; HR-FABMS [M + H]+ m/z 234.1127 (calcd
for C13H16NO3, 234.1124).
2-(1H-Indol-3-yl)ethyl 5-hydroxypentanoate (4): colorless oil; UV
(MeOH) λmax (log ꢀ) 222 (4.33), 282 (3.57) nm; 1H NMR, see Table 1;
13C NMR, see Table 1; HR-FABMS [M + H]+ m/z 262.1444 (calcd
for C15H20NO3, 262.1445).
Preparations of (S)-2-(1H-Indol-3-yl)ethyl 2-hydroxypropanoate
(3a) and (R)-2-(1H-Indol-3-yl)ethyl 2-hydroxypropanoate (3b).
L-Lactic acid (270 mg) was heated in thionyl chloride (30 mL) for 6 h
at 55 °C. After the thionyl chloride was evaporated at low temperature,
CH2Cl2 (20 mL) containing tryptophol (480 mg) and 4-dimethylami-
nopyridine (366 mg) was added, and the mixture was stirred for 6 h at
room temperature. The reaction mixture was diluted with EtOAc,
washed with 0.1 M HCl, and dried over anhydrous Na2SO4. The filtrate
was evaporated to give crude materials, and they were applied to silica
gel column chromatography. The fraction was eluted with n-hexane/
EtOAc (2:1) and was further purified by preparative RP-HPLC (column:
Capcell-Pak C18 SG120, 15 × 250 mm, Shiseido; mobile phase: 32%
CH3CN/H2O) to yield 3a (47.4 mg). Similarly, (R)-2-(1H-indol-3-
yl)ethyl 2-hydroxypropanoate (3b, 4.0 mg) was prepared from D-lactic
acid (45 mg) and tryptophol (81 mg).
Measurement of DPPH Radical Scavenging Activity. DPPH
radical scavenging assay was performed by the modified method
presented previously.3-9 An ethanolic solution of the sample (750 µM,
1 mL) was mixed with a 500 µM DPPH ethanolic solution (0.5 mL)
and 0.1 M acetate buffer (pH 5.5, 1 mL). The reaction mixture was
left to stand for 48 h, at which time the absorbance of the mixture was
measured at 517 nm. The DPPH radical scavenging activity was
determined by comparison of the absorbance of sample with that of a
blank control. BHT (butylhydroxytoluene; 2,6-di-tert-butyl-4-meth-
ylphenol) was used as a positive control at the same concentration as
other samples.
Acknowledgment. We are grateful to M. Sugiyama for assistance
in collecting the marine sponge.
Supporting Information Available: NMR spectra of 1-5 and
spectroscopic data and additional information on the known compounds
References and Notes
(1) Madamanchi, N. R.; Vendrov, A.; Runge, M. S. Arterioscler. Thromb.
Vasc. Biol. 2005, 25, 29–38.
(2) Ames, B. N.; Gold, L. S.; Willett, W. C. Proc. Natl. Acad. Sci. U.S.A.
1995, 92, 5285–5265.
(3) Abe, N.; Murata, T.; Hirota, A. Biosci. Biotechnol. Biochem. 1998,
62, 661–666.
(4) Abe, N.; Murata, T.; Yamamoto, K.; Hirota, A. Tetrahedron Lett. 1999,
40, 5203–5206.
(5) Ito, C.; Abe, N.; Hirota, A. Biosci. Biotechnol. Biochem. 1999, 63,
1993–1996.
(6) Washida, K.; Abe, N.; Sugiyama, Y.; Hirota, A. Biosci. Biotechnol.
Biochem. 2007, 71, 1052–1057.
(7) Sugiyama, Y.; Watanabe, K.; Hirota, A. Biosci. Biotechnol. Biochem.
2009, 73, 230–232.
(8) Hirota, A.; Inaba, M.; Chen, Y.-C.; Abe, N.; Taki, S.; Yano, M.;
Kawaii, S. Biosci. Biotechnol. Biochem. 2004, 68, 1372–1374.
(9) Chen, Y.-C.; Sugiyama, Y.; Abe, N.; Kuruto-Niwa, R.; Nozawa, R.;
Hirota, A. Biosci. Biotechnol. Biochem. 2005, 69, 999–1006.
(10) Blois, M. S. Nature 1958, 181, 1199–1200.
(11) SentheShanmuganathan, S.; Elsden, S. R. Biochem. J. 1958, 69, 210–
218.
(12) Kradolfer, P.; Niederberger, P.; Hu¨tter, R. Arch. Microbiol. 1982, 133,
242–248.
(13) Valavanidis, A.; Nisiotou, C.; Papageorgiou, Y.; Kremli, I.; Satravelas,
N.; Zinieris, N.; Zygalaki, H. J. Agric. Food Chem. 2004, 52, 2358–
2365.
(14) Marfey, P. Carlsberg Res. Commun. 1984, 49, 591–596.
(15) Tamura, S.; Suzuki, A.; Aoki, Y.; Otake, N. Agric. Biol. Chem. 1964,
28, 650–652.
(16) Ferna´ndez-Pacho´n, M. S.; Villan˜o, D.; Troncoso, A. M.; Garc´ıa-
Parrilla, M. C. Anal. Chim. Acta 2006, 563, 101–108.
(17) Cano, A.; Alcaraz, O.; Arnao, M. B. Anal. Bioanal. Chem. 2003, 376,
33–37.
(18) Yarrow, D. The Yeasts, A Taxonomic Study, 4th ed.; Elsevier Science
BV: Amsterdam, The Netherlands, 1998; pp 77-100.
(19) Kurtzman, C. P.; Robnett, C. J. Antonie Van Leeuwenhoek 1998, 73,
331–371.
(S)-2-(1H-Indol-3-yl)ethyl 2-hydroxypropanoate (3a): colorless oil;
1
[R]25 -8.8 (c 0.23, MeOH); H NMR (CD3OD, 500 MHz) δ 7.56
D
(1H, d, J ) 8.0 Hz, H-4), 7.32 (1H, d, J ) 8.0 Hz, H-7), 7.09 (1H, s,
H-2), 7.08 (1H, t, H-6), 7.00 (1H, t, J ) 8.0, 7.5 Hz, H-5), 4.38 (2H,
m, H-2′), 4.22 (1H, q, J ) 6.9 Hz, H-2′′), 3.11 (2H, t, J ) 6.9 Hz,
H-1′), 1.31 (3H, d, J ) 6.9 Hz, H-3′′); 13C NMR (CD3OD, 125 MHz)
δ 176.5 (C-1′′), 138.1 (C-7a), 128.7 (C-3a), 123.8 (C-2), 122.3 (C-6),
119.7 (C-5), 119.2 (C-4), 112.2 (C-7), 111.6 (C-3), 67.9 (C-2′′), 66.4
(C-2′), 25.8 (C-1′), 20.6 (C-3′′); HR-FABMS m/z 234.1137 [M + H]+
(calcd for C13H16NO3, 234.1130).
(R)-2-(1H-Indol-3-yl)ethyl 2-hydroxypropanoate (3b): colorless
1
oil; [R]21 +9.3 (c 0.11, MeOH); H and 13C NMR data are identical
D
to those for 3a; HR-FABMS m/z 234.1142 [M + H]+ (calcd for
C13H16NO3, 234.1130).
(20) Altschul, S. F.; Madden, T. L.; Scha¨ffer, A. A.; Zhang, J.; Zhang, Z.;
Miller, W.; Lipman, D. J. Nucleic Acids Res. 1997, 25, 3389–3402.
(21) Kurtzman, C. P. The Yeasts, A Taxonomic Study, 4th ed.; Elsevier
Science BV: Amsterdam, The Netherlands, 1998; pp 273-352.
(22) Glavind, J.; Holmer, G. J. Am. Oil Chem. Soc. 1967, 44, 539–542.
Determination of the Configuration of Compound 3. The natural
product (3) and the synthetic compounds (3a and 3b) were analyzed
by chiral HPLC (column: Ceramospher Chiral RU-2, 4.6 × 250 mm,
Shiseido; mobile phase: MeOH; flow rate: 0.5 mL/min; detection: 280
nm). The retention times of synthetic compounds 3a and 3b were 21.9
and 17.6 min, respectively. Two peaks that correspond to 3a and 3b
NP900483G